title: Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes.
abstract: The clinical characteristics and outcomes of younger (≤ 55 years) patients with chronic lymphocytic leukemia in the era of modern prognostic biomarkers and chemoimmunotherapy are not well understood. Baseline characteristics and outcomes of patients with chronic lymphocytic leukemia ≤ 55 years who were seen at the Mayo Clinic between January 1995 and April 2012 were compared with those of patients >55 years. The overall survival of patients ≤ 55 years was compared to that of the age- and sex-matched normal population. The characteristics of 844 newly diagnosed chronic lymphocytic leukemia patients ≤ 55 years old (median, 50 years) were compared to those of 2324 patients >55 years old (median, 67 years). Younger patients were more likely to have Rai stage I or II disease (P<0.0001), be IGHV unmutated (P=0.002) and express ZAP-70 (P=0.009). These differences became more pronounced when the ≤ 55 age group was sub-stratified into age ≤ 45, 46-50 and 51-55 years. After a median follow-up of 5.5 years, 426 (51%) patients ≤ 55 years old had received treatment, and 192 (23%) had died. The time to treatment was shorter in patients ≤ 55 years than in those older than 55 years (4.0 years versus 5.2 years; P=0.001) and those ≤ 55 years had longer survival (12.5 years versus 9.5 years; P<0.0001). However, patients ≤ 55 years had significantly shorter survival than the age- and sex-matched normal population (12.5 years versus not reached; P<0.0001). Our study is the first comprehensive analysis of younger patients with chronic lymphocytic leukemia in the modern era. Adverse prognostic markers appear more common among young patients. Although the survival of young chronic lymphocytic leukemia patients is longer than that of those >55 years old, their survival relative to the age- and sex-matched normal population is profoundly shortened.
authors.affiliation: shanafelt.tait@mayo.edu.
authors.forename: Sameer A
authors.initials: SA
authors.lastname: Parikh
authors.forename: Kari G
authors.initials: KG
authors.lastname: Rabe
authors.forename: Neil E
authors.initials: NE
authors.lastname: Kay
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Call
authors.forename: Wei
authors.initials: W
authors.lastname: Ding
authors.forename: Susan M
authors.initials: SM
authors.lastname: Schwager
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Bowen
authors.forename: Michael
authors.initials: M
authors.lastname: Conte
authors.forename: Diane F
authors.initials: DF
authors.lastname: Jelinek
authors.forename: Susan L
authors.initials: SL
authors.lastname: Slager
authors.forename: Tait D
authors.initials: TD
authors.lastname: Shanafelt
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000401:mortality* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D016896:Treatment Outcome; D055815:Young Adult
references.citation: Leuk Lymphoma. 2008 Jan;49(1):49-56
references.pmid: 18203011
references.citation: Lancet. 2010 Oct 2;376(9747):1164-74
references.pmid: 20888994
references.citation: Hematology Am Soc Hematol Educ Program. 2010;2010:481-8
references.pmid: 21239840
references.citation: Haematologia (Budap). 2002;31(4):303-11
references.pmid: 12038513
references.citation: Blood. 2011 Jun 16;117(24):6450-8
references.pmid: 21498674
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4378-84
references.pmid: 19652068
references.citation: J Clin Oncol. 2006 Jan 20;24(3):437-43
references.pmid: 16344317
references.citation: Blood. 1999 Jul 15;94(2):448-54
references.pmid: 10397712
references.citation: J Clin Oncol. 2007 Dec 10;25(35):5616-23
references.pmid: 17984186
references.citation: CA Cancer J Clin. 2013 Jan;63(1):11-30
references.pmid: 23335087
references.citation: Blood. 2009 Sep 3;114(10):2044-50
references.pmid: 19553638
references.citation: Leukemia. 2007 Jan;21(1):12-7
references.pmid: 17109028
references.citation: Mayo Clin Proc. 1994 Apr;69(4):323-8
references.pmid: 8170175
references.citation: Nouv Rev Fr Hematol. 1988;30(5-6):411-2
references.pmid: 3222152
references.citation: Leukemia. 2013 Jan;27(1):136-41
references.pmid: 22781591
references.citation: J Clin Oncol. 1999 Dec;17(12):3835-49
references.pmid: 10577857
references.citation: Leukemia. 1993 Aug;7(8):1232-5
references.pmid: 8350623
references.citation: J Clin Oncol. 2006 Oct 1;24(28):4634-41
references.pmid: 17008705
references.citation: J Clin Oncol. 2007 Mar 1;25(7):799-804
references.pmid: 17283363
references.citation: Br J Haematol. 2008 Mar;140(5):537-46
references.pmid: 18275431
references.citation: Semin Oncol. 1998 Feb;25(1):107-16
references.pmid: 9482532
references.citation: Blood. 1975 Aug;46(2):219-34
references.pmid: 1139039
references.citation: Blood. 2008 Jun 15;111(12):5446-56
references.pmid: 18216293
references.citation: Br J Haematol. 2007 Nov;139(3):398-404
references.pmid: 17910629
references.citation: Blood. 1991 Sep 15;78(6):1545-51
references.pmid: 1884021
references.citation: Blood. 2008 May 15;111(10):4916-21
references.pmid: 18309034
references.citation: Hematol Oncol. 1989 Mar-Apr;7(2):127-37
references.pmid: 2921008
references.citation: Blood. 1996 Jun 15;87(12):4990-7
references.pmid: 8652811
references.citation: Blood. 2006 Feb 1;107(3):885-91
references.pmid: 16219797
references.citation: Hematology Am Soc Hematol Educ Program. 2010;2010:90-2
references.pmid: 21239776
references.citation: J Clin Oncol. 2007 Mar 1;25(7):793-8
references.pmid: 17283364
references.citation: Cancer. 2010 Oct 15;116(20):4777-87
references.pmid: 20578179
references.citation: Lancet. 2007 Jul 21;370(9583):230-239
references.pmid: 17658394
references.citation: J Clin Oncol. 2008 Oct 20;26(30):4912-20
references.pmid: 18794548
references.citation: Eur J Haematol. 1994 Apr;52(4):216-21
references.pmid: 8005231
references.citation: Hematology Am Soc Hematol Educ Program. 2010;2010:82-9
references.pmid: 21239775
references.citation: Blood. 2008 Aug 15;112(4):975-80
references.pmid: 18411418